|
1
|
Dhvani Shah et al. [24]
|
HF-related hospitalizations and other resource use
|
EQ-5D
|
NA
|
Monthly
|
4 (HF hospitalization, death, health-related quality of life and device-specific treatment effects)
|
baseline hospitalization risk and Medicare-specific costs
|
Network meta-analysis
|
7.97 yrs CRT-D VS 7.47 yrs ICD
|
Regression equations
|
|
2
|
Mealing et al. [22]
|
Hospitalizations costs and cross-manufacturer average selling prices for both intervention and leads
|
EQ-5D
|
NA
|
Yearly
|
4 (mortality, hospitalization , health-related quality of life, and device-related effects)
|
National databases for costs and clinical literature and expert opinion
|
Network meta-analyses
|
NA
|
Individual patient based regression
|
|
3
|
Woo et al. [20]
|
HF-related hospitalizations and costs related to device implantation, extraction, reimplantation
|
EQ-5D
|
Stable, hospitalization, lead failure, lead infection, death
|
Monthly
|
4 (Successful with no complications, Successful with complications, Not successful, Procedural death)
|
Clinical trials, clinical registries, claims data from centers for medicare and medicaid services, and centers for disease control and prevention life tables
|
Meta-analysis of trials
|
9.8 yrs CRT-D VS 8.8 yrs ICD
|
ICER
|
|
4
|
Bertoldi et al. [23]
|
costs of consultations, diagnostic tests, procedures, hospital admissions, device implantation and complications
|
EQ-5D
|
Stable, lead failure, hospitalization, lead infection, death
|
Monthly
|
3 (failure, success, death)
|
Brazilian Ministry of Health (public healthcare system)
|
Meta-analysis of trials
|
7.54 yrs CRT-D VS 6.9 yrs ICD
|
ICER
|
|
5
|
Noys et al. [21]
|
Hospitalization for implantation, inpatient and outpatient costs, emergency room
|
EQ-5D
|
NA
|
Every 6 month
|
2 (HF events, death)
|
National medicare reimbursement rates
|
MADIT-CRT study
|
3.61 yrs CRT-D VS 3.54 yrs ICD
|
ICER
|
